Submitted by Anonymous (not verified) on 29 May 2026 - 14:00
Human medicines European public assessment report (EPAR): Teriflunomide Viatris (previously Teriflunomide Mylan), teriflunomide, Date of authorisation: 09/11/2022, Revision: 8, Status: Authorised
Source: